TSS
CMMB

Two Sigma Securities’s Chemomab Therapeutics CMMB Stock Holding History

Two Sigma Securities’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,526
Closed -$24.1K – 1581
2025
Q1 		$24.1K Buy
+5,526
New +$38.8K ﹤0.01% 1075
2024
Q4 		– Sell
-9,985
Closed -$62.7K – 1911
2024
Q3 		$62.7K Buy
+9,985
New +$56K ﹤0.01% 2346
2024
Q2 		– Sell
-6,546
Closed -$20.4K – 3058
2024
Q1 		$20.4K Buy
+6,546
New +$16.9K ﹤0.01% 2672

Other funds holding CMMB

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return